Barco has received FDA 510(k) pre-market clearance for its latest version of its VOXAR 3D advanced visualization suite that reportedly further enhances the digital imaging workflow with its seamless integration into PACS, which allows radiologists to increase their efficiency and report studies faster.
The new VOXAR 3D suite comes with a full set of integrated clinical applications, including VOXAR 3D COLONMETRIX for CT colonography and VOXAR 3D PET-CT FUSION for the interpretation of whole body FDG oncology studies.